Stock Chart
MRUS
Type: SELL wallstreet
Strike: $100
Premium: $0.50
Expiry: Jan 15, 2027
Target: $97
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About MRUS - Merus N.V. Common Shares
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
Key Statistics
More MRUS Analysis
This MRUS stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track MRUS's price movements with trendlines, gamma walls, and key support/resistance levels.